Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 3, 2008, Pages 378-384

  Merlo Pich, E ^a   Gomeni, R ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; PAROXETINE; PLACEBO;

ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DATA BASE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EVALUATION; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MATHEMATICAL ANALYSIS; MODEL; MULTICENTER STUDY; PATIENT PARTICIPATION; PATIENT RECRUITMENT; PERFORMANCE; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SIGNAL DETECTION THEORY; THEORY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HUMANS; LOGISTIC MODELS; MULTICENTER STUDIES AS TOPIC; PAROXETINE; PATIENT SELECTION; SIGNAL DETECTION (PSYCHOLOGY); TREATMENT OUTCOME;

EID: 49949094420     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.70     Document Type: Article

References (17)

1. Khan, A., Detke, M., Khan, S.R.F. & Mallinckrodt, C. Placebo response and antidepressant clinical trial outcome. J. Nerv. Ment. Dis. 191, 211-218 (2003).
2. Stein, D.J., Baldwin, D.S., Dolberg, O.T., Despiegel, N. & Bandelow, B. Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J. Clin. Psychiatry 67, 1741-1746 (2006).
3. Alexopoulos, G.S., Kanellopoulos, D., Murphy, C., Gunning-Dixon, F., Katz, R. & Heo, M. Placebo response and antidepressant response. Am. J. Geriatr. Psychiatry 15, 149-158 (2007).
4. Allan, L.G. & Siegel, S. A signal detection theory analysis of the placebo effect. Eval. Health Prof. 25, 410-420 (2002).
5. Trivedi, M.H. & Rush, A.J. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 11, 33-43 (1994).
6. Benedetti, F., Mayberg, H.S., Wager, T.D., Stohler, C.S. & Zubieta, J.K. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25, 10390-10402 (2005).
7. Schatzberg, A.F. & Kraemer, H.C. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol. Psychiatry 47, 736-744 (2000).
8. Kobak, K.A., Feiger, A.D. & Lipsitz, J.D. Impact of interview quality on signal detection. Am. J. Psychiatry 162, 628 (2005).
9. Nierenberg, A.A. & Wright, E.C. Evolution of remission as the new standard in the treatment of depression. J. Clin. Psychiatry 60, 7-11 (1999).
10. Taylor, W.D., McQuoid, D.R., Steffens, D.C. & Krishnan, K.R. Is there a definition of remission in late-life depression that predicts later relapse? Neuropsychopharmacology 29, 2272-2277 (2004).
11. Gomeni, R. & Merlo-Pich, E. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. Br. J. Clin. Pharmacol. 63, 595-613 (2007).
12. Fava, M., Evins, A.E., Dorer, D.J. & Schoenfeld, D.A. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother. Psychosom. 72, 115-127 (2003).
13. Huitfeldt, B. & Montgomery, S.A. Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms - a combined analysis of four British clinical trials in depression. Acta. Psychiatr. Scand. Suppl. 308, 55-69 (1983).
14. Pepe, M.S. An interpretation for the ROC curve and inference using GLM procedures. Biometrics 56, 352-359 (2000).
15. Liu, H., Li, G., Cumberland, W.G. & Wu, T. Testing statistical significance of the area under a receiving operating characteristics curve for repeated measures design with bootstrapping. J. Data Sci. 3, 257-278 (2005).
16. Spiegelhalter, D.J., Thomas, A., Best, N.G. & Lunn, D. WinBUGS, Version 1.4, User Manual. (MRC Biostatistics Unit, Cambridge, UK, 2001).
17. Youden, W.J. An index for rating diagnostic tests. Cancer 3, 32-35 (1950).